Skip to main content

Infleqtion, Inc.

For the period ended Jun 30, 2026. Filed Aug 18, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 18, 2026

INFQ$9.35-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited)

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited; in thousands, except share amounts)

Convertible Redeemable Preferred Stock · Stockholders’ Equity (Deficit)
Series Seed · Series Seed II · Series A · Series B · Series B-1 · Series C · Series C-1 · Common Stock · AdditionalPaid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity (Deficit)
Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount
Balances as of March 31, 2026—$——$——$——$——$——$——$—216,471,927$22$846,657$(263,215)$(75)$583,389
Net loss—————————————————(24,695)—(24,695)
Stock-based compensation expense————————————————12,066——12,066
Stock options exercised——————————————8,206,62013,955——3,956
Other comprehensive loss——————————————————(336)(336)
Balances as of Settlement of restricted stock units——————————————813—————
Balances as of Warrants exercised——————————————1,825—3$—$—3
Balances as of June 30, 2026—$——$——$——$——$——$——$—224,681,185$23$862,681$(287,910)$(411)$574,383
Convertible Redeemable Preferred Stock · Stockholders’ Equity (Deficit)
Series Seed · Series Seed II · Series A · Series B · Series B-1 · Series C · Series C-1 · Common Stock · AdditionalPaid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity (Deficit)
Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount
Balances as of March 3120258,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,9907,124,869$22,5037,945,030$26,35116,641,244$2$17,243$(207,088)$776$(189,067)
Net loss—————————————————(9,186)—(9,186)
Convertible redeemable preferred stock issue, net——————————39,891,01449,222————————
Stock-based compensation expense————————————————769——769
Stock options exercised——————————————497,714—413——413
Other comprehensive income——————————————————(22)(22)
Balances as of June 30, 20258,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,99047,015,883$71,7257,945,030$26,35117,138,958$2$18,425$(216,274)$754$(197,093)
Convertible Redeemable Preferred Stock · Stockholders’ Equity (Deficit)
Series Seed · Series Seed II · Series A · Series B · Series B-1 · Series C · Series C-1 · Common Stock · AdditionalPaid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity (Deficit)
Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount
Balances as of December 31, 202524,871,033$6,52627,499,984$10,411101,515,976$36,658113,956,319$112,14532,419,574$32,99060,399,952$71,73322,869,771$26,35150,227,011$5$21,928$(233,496)$906$(210,657)
Conversion of stock(16,230,759)—(17,946,404)—(66,249,009)—(74,367,538)—(21,156,913)—(39,416,820)—(14,924,741)—(32,777,991)(3)3———
Balances as of December 31, 2025 effect of reverse recapitalization8,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,99020,983,132$71,7337,945,030$26,35117,449,020$2$21,931$(233,496)$906$(210,657)
Net loss—————————————————(54,414)—(54,414)
Stock-based compensation expense————————————————20,359——20,359
Stock options exercised——————————————9,322,16314,726——4,727
Merger recapitalization(8,640,274)(6,526)(9,553,580)(10,411)(35,266,967)(36,658)(39,588,781)(112,145)(11,262,661)(32,990)(20,983,132)(71,733)(7,945,030)(26,351)133,240,42513296,801——296,814
CCX shares recapitalized, net of equity issuance costs——————————————64,666,9397518,861——518,868
Other comprehensive loss——————————————————(1,317)(1,317)
Balances as of Settlement of restricted stock units——————————————813—————
Balances as of Warrants exercised——————————————1,825—3——3
Balances as of June 30, 2026—$——$——$——$——$——$——$—224,681,185$23$862,681$(287,910)$(411)$574,383
Convertible Redeemable Preferred Stock · Stockholders’ Equity (Deficit)
Series Seed · Series Seed II · Series A · Series B · Series B-1 · Series C · Series C-1 · Common Stock · AdditionalPaid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity (Deficit)
Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount
Balances as of 12/31/202424,871,033$6,52627,499,984$10,411101,515,976$36,658113,956,319$112,14532,419,574$32,99020,508,938$22,50322,869,771$26,35145,512,715$5$15,751$(201,269)$360$(185,153)
Conversion of stock(16,230,759)—(17,946,404)—(66,249,009)—(74,367,538)—(21,156,913)—(13,384,069)—(14,924,741)—(29,701,456)(3)3———
Balance at December 31, 2024, effect of reverse recapitalization8,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,9907,124,869$22,5037,945,030$26,35115,811,259$2$15,754$(201,269)$360$(185,153)
Net loss—————————————————(15,005)—(15,005)
Convertible redeemable preferred stock issue, net——————————39,891,01449,222————————
Stock-based compensation expense————————————————1,887——1,887
Stock options exercised——————————————1,327,699—784——784
Other comprehensive income——————————————————394394
Balances as of June 30, 20258,640,274$6,5269,553,580$1041135,266,967$36,65839,588,781$112,14511,262,661$32,99047,015,883$71,7257,945,030$26,35117,138,958$2$18,425$(216,274)$754$(197,093)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.